Undergrad Pharmaceutical Project Management Intern at Eli Lilly and Company

Indianapolis, Indiana, United States

Eli Lilly and Company Logo
Not SpecifiedCompensation
InternshipExperience Level
InternshipJob Type
NoVisa
Pharmaceutical, HealthcareIndustries

Requirements

  • Seeking a Bachelor’s degree and actively enrolled in a tech or scientific discipline (e.g. Pharmaceutical Project Management, Data Sciences, Chemistry, Biology, Engineering, Finance, Computer Sciences or health-related field)
  • Will graduate by August 2028
  • Qualified applicants must be authorized to work in the United States on a full-time basis (Lilly will not provide support for or sponsor F-1 OPT, F-1 STEM OPT, J-1, H-1B, TN, O-1, E-3, H-1B1, or L-1 visas)
  • Major with a concentration/emphasis in project management, healthcare business, or organizational leadership (preferred)
  • Demonstrated leadership and ability to influence (preferred)
  • Clearly demonstrated analytical thought and aptitude (preferred)
  • Strong problem-solving skills (preferred)
  • Excellent communication, teamwork, and interpersonal skills (preferred)
  • Language fluency in English (written and verbal) (preferred)

Responsibilities

  • Develop transferable skills in business, project management, and leadership
  • Learn about the drug development process and how project managers lead cross-functional teams to create and execute development strategies for new therapies
  • Participate in a project to understand how the therapeutic area and disease state affect the development plan, showcasing leadership, teamwork, and communication skills by presenting findings to Project Management leadership
  • Participate in activities to get to know Lilly's drug development organization, improve comprehension of Lilly's position in the pharmaceutical sector, connect with Project Management leaders, and learn why Indianapolis is an excellent city to begin a career

Skills

Project Management
Drug Development
Leadership
Teamwork
Communication
Cross-functional Teams

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters
1876Year Founded
$1,180.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.
Potential construction delays in Indiana could affect GLP-1 drug production timelines.
Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.
Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.
FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.
Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.
Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI